Busting the last-resort myth in type 2 diabetes treatment

6 reasons to consider glucagon-like peptide-1 receptor agonists (GLP-1RA) as second-line therapy

Glucagon-like peptide-1 receptor agonists (GLP-1RA) are increasingly conventional second-line agents for hyperglycaemia in type-2 diabetes, with the Australian Diabetes Society and international guidelines elevating them into consideration as part of a patient-centred approach.

A/Prof Samantha Hocking
A/Prof Samantha Hocking